The current price of AXSM is $129.80 — it has decreased by 5.26% since the previous close. Data as of Nov 5, 2026.
AXSM is down 9.38% over the past week, down 26.70% over the past month and down 4.34% over the past year. The price is below its 200-day moving average of $198.71.
Analysts' average 12-month price target for AXSM is $277.64, which implies 113.90% upside from the current price. Individual estimates range from $238.00 to $380.00.
Of the 22 analysts covering Axsome Therapeutics, Inc., 3 rate it a strong buy, 18 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Axsome Therapeutics, Inc. has a market capitalization of $6.83B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Axsome Therapeutics, Inc. posted a loss of $0.25 per share against an estimate of -$0.6343, beating expectations by 60.58%. Upcoming reports are listed in the earnings calendar.
Axsome Therapeutics, Inc. reported revenue of $259.69M in its most recent quarter, which has increased by 51.87% compared with the same quarter a year earlier. Analysts had expected $249.19M.
Axsome Therapeutics, Inc. has not paid any dividends over the past year.
Companies most comparable to Axsome Therapeutics, Inc. include Neurocrine Biosciences, Inc., Jazz Pharmaceuticals plc, Praxis Precision Medicines, Inc., Definium Therapeutics, Inc. and Xenon Pharmaceuticals Inc.
In the latest trading session AXSM moved between $128.99 and $137.56, a range of 6.60% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Axsome Therapeutics, Inc. shows a strong sell rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks AXSM has traded between $123.00 and $260.19. The current price is 50.11% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.